American Association for Cancer Research

2011 Minority Scholar in Cancer Research Awards A-L

 Gregory Adams

Gregory Adams Jr., B.S.
Morehouse School of Medicine, Atlanta, GA
“My long-range educational and training goal is to continue and contribute to the understanding and identification of biomarkers of colorectal cancer and mitochondrial genomes. Furthermore, aspiring for a Ph.D. in cancer biology and a M.D., moreover, serving as a physician scientist, I will be able to integrate the clinical and biomedical research approach to reduce minority colorectal cancer progression.”

Abstract #3713 Oxidative stress and mitochondrial DNA mutations in serous ovarian carcinoma. Poster Session: Tuesday, April 5, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

Abstract #3806 Mitochondrial DNA (MtDNA) analysis in Colorectal Neoplasia. Poster Session: Tuesday, April 5, 2011, 1:00 p.m. - 5:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Samuel Asfaha

Samuel Asfaha, M.D., Ph.D.
Columbia University, New York, NY
“I plan to complete my postdoctoral research work at Columbia University in New York and then move on to faculty position at a university in which I will be able to carry on my medical research as well as fulfill my duties as a clinical gastroenterologist.”

Abstract #5186 Lineage Tracing of Cytokeratin 19 Labels Gastric, Intestinal and Colonic Stem Cells. Poster Session: Wednesday, April 6, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C 

 Matthew Banegas

Matthew P. Banegas, Ph.D.
University of Washington, Seattle, WA.
“My long-term goal is to become an accomplished researcher and mentor. As a Hispanic/Latino cancer researcher I hope to access, effectively communicate, and perform research with communities of color where more research is warranted. There is relatively little empirical research on breast cancer risk prediction among ethnic minority women, especially Hispanics/Latinas. Through accurately researching and identifying the risk of breast cancer, strategies can be developed to reduce the burden and mortality from this disease.”

Abstract #3717 Evaluation and comparison of breast cancer risk prediction models for Hispanic and non-Hispanic White women in the Women’s Health Initiative. Poster Session: Tuesday, April 5, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Tesfaye Baye

Tesfaye M. Baye, Ph.D.
University of Cincinnati and Cincinnati Children's Hospital Medical Center, Cincinnati, OH
“My current research focuses on the use of admixture analysis to localize ancestry specific disease susceptibility genes. I recently developed a novel panel of genome-wide ancestry informative markers (AIMs) for (1) ancestry inference, (2) admixture mapping, and (3) structured association testing. My research interest and career goals in population, quantitative and statistical genomics/genetics of complex traits include understanding and dissecting how biologic predisposition and environmental exposures interact to shape racial disparities in complex disorders, through research and attendance at national symposia.”

Abstract #2746 Genomic Data Mining for Selecting Informative Markers for Ancestry. Poster Session: Monday, April 4, 2011, 1:00 p.m. - 5:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Selina Beasley

Selina A. Beasley, B.S.
North Carolina A&T State University, Greensboro, NC
“I plan to obtain a Ph.D. in biomedical sciences. After obtaining my Ph.D. I plan to work on cancer research for the NIH or the private sector for five to 10 years. Then, I plan to create my own biomedical company and run my own lab.”

Abstract #2933 Inhibition of MAPK signaling prevents Fra-1-mediated CD44 expression in human brain tumor cells. Poster Session: Tuesday, April 5, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Alaina Boyer

Alaina P. Boyer, Ph.D.
Washington University in St. Louis, Saint Louis, MO
“I plan to continue my work and research in the cancer field. I intend to use the resources that AACR has available to determine where and what opportunities currently exist as I come to the end of my postdoctoral training. I am fully invested in remaining in the cancer field and use the skills I have gained to improve tumor responsiveness to different therapies. Ultimately, I would like to have a more translational role in research and seeing the research make it to the actual patients in a more efficient manner.”

Abstract #5126 Development of a high throughput quantitative phosphoproteomic method to study Trastuzumab resistance. Poster Session: Wednesday, April 6, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Jeffrey Bruce

Jeffrey P. Bruce, B.Sc.
University of Toronto, Toronto, ON
“I have recently reclassified from the M.Sc. stream into the Ph.D. stream in the department of medical biophysics at the University of Toronto. Upon completion of my doctoral degree, I plan to pursue cancer research further - likely in the form of a postdoctoral fellowship. I have a particular interest in epithelial malignancies, but cancer research as a whole is my passion, therefore I am open to pursuing other research avenues during my postdoctoral training. Eventually, my goal is to become a principal investigator at a reputable cancer research institute.”

Abstract #3967 Identification of Metadherin as a Novel Target of miR-375 in Head and Neck Cancer. Poster Session: Tuesday, April 5, 2011, 1:00 p.m. - 5:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Teleka Calderon

Teleka Calderon, B.S., B.A.
Loma Linda University, Loma Linda, CA.
“My research training has been in the areas of biochemical and molecular biology techniques, and I will continue to update myself with regards to cutting-edge technique. Attending AACR 2011 is a part of this continuing technical education. As a combined degree student, I have the overall goal of being a well trained physician-scientist in an oncology-related field. I have seen the lack of representation of physicians in research firsthand, and am committed to bridging the gap between research and practice."

Abstract #5605 Differential expression of fatty-acid binding proteins 3 and 5: Role in survival disparity among African-American women with breast cancer. Poster Session: Wednesday, April 6, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Jamaica Cass

Jamaica Cass, B.Sc.
Queen's University, Kingston, ON
“I hope to finish my Ph.D. in the summer of 2013 and then attend medical school. It is my hope to work as a physician scientist in either breast oncology or pathology.”

Abstract #3207 Automated quantitative analysis of p53, cyclin D1 and pErk expression in breast carcinoma does not differ from expert pathologist scoring and correlates well with clinico-pathological characteristics. Poster Session: Tuesday, April 5, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C 

 Michelle Collazo

Michelle M. Collazo, B.S.
University of South Florida and H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
“I will be completing my thesis work in summer 2011 in order to receive a Ph.D. in cancer biology. I have acquired an interest in translational and clinical research that involves the use of more holistic individualized methodology, which combines behavioral, nutritional and medicinal approaches, for the cure and prevention of cancer. Eventually, I would like to get another doctoral degree in holistic health and nutrition that would allow me to consult with cancer patients in order to provide them with other treatment alternatives, if they indeed exist and are effective. All the while, I would like to continue teaching undergraduate and/or graduate level courses.”

Abstract #3647 Characterization of the relationship between mature neutrophils and tumor associated granulocytic myeloid-derived suppressor cells. Poster Session: Tuesday, April 5, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Valerie Cortez

Valerie A. Cortez, B.S.
The University of Texas Health Science Center, San Antonio, TX
“My long-term goal is to discover novel pathways that contribute to the development of hormonal driven cancers in women and ultimately translate my findings into development of better strategies for treatment of hormonal and therapy-resistant cancers. To achieve this goal, I have begun rigorous and comprehensive training in hormonal cancer biology with disciplined focus on acquiring skills and knowledge in pursuit of a career as a cancer researcher. After competition of predoctoral training, I will undergo a postdoctoral training in breast cancer research at UT MD Anderson Cancer Center or Dana Farber Cancer Institute at Harvard medical School before seeking a tenure-track faculty position in an excellent research environment.”

Abstract #73 PELP1 is a novel reader of chromatin modifications: Implications in cancer progression. Poster Session: Sunday, April 3, 2011, 1:00 p.m. - 5:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

Abstract #1733 Therapeutic significance of ER-PELP1 axis in blocking endocrine therapy resistance. Poster Session: Monday, April 4, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Mohammad Daremipouran

Mohammad Daremipouran, Ph.D.
Howard University, Washington, D.C.
I would like to extend my career to translational research especially on cancer prevention and epidemiology of prostate cancer in health disparities. To achieve my goals I have already started to focus more on biostatistics, epidemiology and clinical genetics of prostate cancer as it is reflected from my dissertation title, ‘UV exposure, vitamin D, and risk of prostate cancer in African-Americans.’ Now, I am looking for a fellowship program in cancer prevention or clinical molecular genetics.”

Abstract #3033 NKX2-5, a potential tumor suppressor gene in prostate cancer. Poster Session: Tuesday, April 5, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Albert Davalos

Albert R. Davalos, Ph.D.
Buck Institute for Age Research, Novato, CA
“My long-term educational and research training goals entail transitioning from basic to clinical/translation cancer research. Ultimately, I intend to transition into patient tissue and serum samples to investigate the role of senescent associated secreted factors in inflammation-induced cancer progression. Due to proximity to several medical research institutions and biomedical research companies, I would like to utilize their resources to synergize my basic research experience with knowledge gained by working with clinicians. My collaborators can provide the additional training required to work with patient samples. Thus, I will expand the scope of my research experience.”

Abstract #4507 Small molecule inhibitor of M.D.M2 induces p53-dependent HMGB1 secretion followed by apoptosis in cancer cells and incomplete senescence in normal fibroblasts. Poster Session: Tuesday, April 5, 2011, 1:00 p.m. - 5:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Ivory Dean

Ivory Dean, B.S.
Wayne State University School of Medicine, Detroit, MI
“My long-term goal is to become an independent scientist. As an independent scientist, I would like to have my own lab and serve as a mentor to students. As preparation for becoming an independent scientist, I would like to continue my scientific training with a postdoctoral fellowship.”

Abstract #3359 Maspin induces MET in prostate cancer cells cultured in 3D-collagen I. Poster Session: Tuesday, April 5, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Lissette Delgado-Cruzata

Lissette Delgado-Cruzata, Ph.D.
Columbia University Mailman School of Public Health, New York, NY
“I am a postdoctoral trainee in the field of cancer epidemiology. Most of my current research is related to the study of epigenetic variations associated with carcinogenesis. I work in the development of biomarkers that indicate variations in the epigenetic profile of persons with cancer, such as changes in DNA methylation and miRNA expression levels. My long-term goals are to become an independent researcher in the field of molecular epidemiology, use my position as principal investigator to develop biomarkers that will allow us to better understand cancer risk and prognosis, and to attain a faculty position as a professor in a research university.”

Abstract #295 Detection of hypomethylation of LINE1 on peripheral white blood cells and plasma DNA in US hepatocellular carcinoma patients. Poster Session: Sunday, April 3, 2011, 1:00 p.m. - 5:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

Abstract # 3754 DNA methylation in hepatocellular carcinoma..Poster Session: Tuesday, April 5, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

Abstract #4198 Mismatch repair polymorphisms and breast cancer risk in the Metropolitan New York Breast Cancer Family Registry..Poster Session: Tuesday, April 5, 2011, 1:00 p.m. - 5:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Yartiza Diaz-Algorri

Yaritza Diaz-Algorri, M.S.
University of Puerto Rico Comprehensive Cancer Center, San Juan, PR
“Currently, I am working with the topic of my doctoral dissertation in the epidemiology doctoral program. I am interested to continue studies in epidemiology in order to expand my knowledge in this area and contribute to the cancer, epigenetics, nutrition and metabolism research in my community and country.”

Abstract #1918 Type 2 diabetes mellitus and colorectal neoplasia risk in Puerto Rican Hispanics: A case-control study Poster Session: Monday, April 4, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

Abstract #3767 Familial colorectal cancer registry in Hispanics: A feasibility study. Poster Session: Tuesday, April 5, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

Abstract #1813 Implementation and outcomes of a community-based educational program in colorectal cancer prevention. Poster Session: Monday, April 4, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

Abstract #1838 Survival and gender disparities in Puerto Rican Hispanics with colorectal cancer: A five-year analysis. Poster Session: Monday, April 4, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Alexandra Fajardo

Alexandra M. Fajardo, B.S.
University of New Mexico, Albuquerque, NM
“My immediate goal is to graduate with my Ph.D. in biomedical sciences this spring. I am currently pursuing academic postdoctoral positions with a cancer research focus. My ultimate career goal is to work in industry on the development of novel targeted cancer therapeutics. My ultimate goal is to develop chemotherapeutics with high efficacy and minimal toxicity.”

Abstract #2073 Curcumin analog 27 induced reactive oxygen species mediate loss of androgen receptor protein expression in human prostate cancer cells. Poster Session: Monday, April 4, 2011, 1:00 p.m. - 5:00 p.m., Orange County Convention Center, Exhibit Hall 4A-C

 Mulu Geletu

Mulu Geletu, Ph.D.
Queen's University, Kingston, ON
“My career goal is to acquire a solid base in cancer research and become a principal investigator, and eventually head my own team of researchers, train new scientists willing to undertake future scientific challenges. I am truly fascinated by the idea of being at the forefront of the battle against cancer and to eventually contribute to better treatments and diagnostic tests to eradicate this disease.”

Abstract #1323 Reciprocal regulation of Stat3 and caveolin-1 in normal fibroblasts and breast carcinoma lines. Poster Session:  Monday, April 4, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall 4A-C

Abstract #3123 Differential effects of polyoma virus middle tumor antigen mutants upon gap junctional, intercellular communication. Poster Session: Tuesday, April 5, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall 4A-C

 Evan Gomes

Evan Gomes, Ph.D., M.P.H.
MD Anderson Cancer Center Orlando Cancer Research Institute, Orlando, FL
“As my primary goal, I would like initiate a successful career focused on understanding the molecular pathogenesis of pancreatic cancer and to make significant contributions to the field of pancreatic cancer research. My career objective is to gain specialized expertise as a pancreatic cancer researcher that will enable me to make a significant and noteworthy contribution to the field.”

Abstract #1237 Role of Src in resistance to anoikis in detached pancreatic cancer cells. Poster Session: Monday, April 4, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall 4A-C

 Alicia Goyeneche

Alicia A. Goyeneche, Ph.D.
University of South Dakota, Vermillion, SD
“My long-term goal in biomedical research is to become an outstanding member of the multidisciplinary translational research team. The next step towards my career independence will be to write a competitive collaborative proposal based on the problematic of peritoneal ovarian cancer metastasis. I would like to establish a better understanding of how the peritoneal microenvironment influences the spread of the ovarian cancer cells, and to provide new alternative therapeutic approaches to mitigate or eliminate recurrence.”

Abstract #2362 Antimetastatic potential of the antiprogestin mifepristone in cancer cells. Poster Session: Monday, April 4, 2011, 1:00 p.m. - 5:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

Abstract #4546 Antiprogestin mifepristone inhibits the growth of cancer cells of reproductive and nonreproductive origin regardless of progesterone receptor expression. Poster Session: Tuesday, April 5, 2011, 1:00 p.m. - 5:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

Abstract #363 Antiprogestin mifepristone improves the efficacy of the combination therapy cisplatin/paclitaxel in human ovarian carcinoma cells in vitro. Poster Session: Sunday, April 3, 2011, 1:00 p.m. - 5:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 James Harris

James E. Harris Jr., M.D.
Johns Hopkins Hospital, Baltimore, MD
“My long-term career goal is to become an academic surgeon after completing a fellowship in surgical oncology where ideally I will dedicate 2/3 of my career to clinical and administrative duties and 1/3 to cancer-related research. Ultimately, after many years of practice and advancing to full professor, I would like to become a division chief and eventually chief of surgery within an academic surgical setting.”

Abstract #1600 A xenograft model of spontaneous metastases in NOD SCID mice of human non-small cell lung cancer. Poster Session: Monday, April 4, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

Abstract #2618 DNMT1 as a marker of differential sensitivities to epigenetic therapy of a Kras mutant and Kras wild type human non small cell lung cancer cell line. Poster Session: Monday, April 4, 2011, 1:00 p.m. - 5:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Ashley Huderson

Ashley C. Huderson, B.S.
Meharry Medical College, Nashville, TN
“Upon successful completion of my doctoral degree from Meharry Medical College, I would like to further my training by doing a postdoctoral fellowship at a prestigious cancer research institute. After completing my postdoctoral training, I plan to conduct cancer-related research at a minority institution. Most minority institutions lack research opportunities for their students due to a lack of well-trained faculty, facilities and funding. I would like to change the face of research by turning such institutions into well-known research facilities.”

 Alicia Hulbert

Alicia Hulbert, M.D.
John Hopkins University School of Medicine, Baltimore, MD
“My long-range educational goals are to increase my knowledge in the etiology, prevention, diagnosis and treatment of HIV lung cancer patients, and to become an independent research scientist with the goal of advancing science in this arena. My long-term goals include combining my clinical skills and research experience to develop new interventions to decrease HIV-lung cancer positive individuals across racial and ethnic groups both domestically and internationally.”

Abstract #2618 DNMT1 as a marker of differential sensitivities to epigenetic therapy in non small cell lung cancer. Poster Session: Monday, April 4, 2011, 1:00 p.m. - 5:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

Abstract #3679 Preliminary results from a patient group, excluded from the National Lung Cancer Screening Trial, who are at high risk for lung cancer- heavy smokers with HIV. Poster Session: Tuesday, April 5, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Amin Ismail

Amin Ismail, Ph.D.
University of Rochester, Rochester, NY
“My long-term goal is to have enough of a publication record to be able to apply for grant support and start my career as an independent investigator. I also have the objective of collaboration with researchers in Egypt to disseminate the cutting edge biomedical research technology I am learning in the U.S. Because cancer biology has become a distinct science that parallels the basic chemistry, biology and physics, I am planning to spend my life contributing new knowledge to it.”

Abstract #3825 Prognosis of esophageal adenocarcinoma is dependent on early G1 cyclin-dependent kinase activity. Poster Session: Tuesday, April 5, 2011, 1:00 p.m. - 5:00 p.m., Orange County Convention Center, Exhibit Hall A4-C 

 Patrick Joseph

Patrick Joseph, M.S.
Florida A&M University, Tallahassee, FL
“Teaching and conducting research at a minority institution, preferably at a college of pharmacy, is my long-range educational and research training goal. I want to teach medicinal chemistry and continue developing anti-ER-positive-and-ER-negative breast cancer agents.”

Abstract #3238 Synthesis and evaluation of 17-oximino-estrone derivatives as potential anti-breast cancer agents. Poster Session: Tuesday, April 5, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Dana-Lynn Koomoa-Lange

Dana-Lynn T. Koomoa-Lange, Ph.D.
University of Hawaii at Hilo College of Pharmacy, Hilo, HI
“I would like to be a tenured professor at an academic institution where I will contribute to the teaching responsibilities at that institution, and maintain an extramurally funded research program in cancer research. I would also like to be able to participate in programs, and develop new programs, that focus on increasing the ethnic diversity of University students and faculty in STEM fields. I am particularly interested in programs that increase Native Hawaiian participation in STEM.”

Abstract #1423 Effects of DFMO-based combination therapy in advanced stage neuroblastoma. Poster Session: Monday, April 4, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Adeyinka Laiyemo

Adeyinka O. Laiyemo, M.P.H.
Howard University, Washington, D.C.
“My long-range goal is to be a well-funded independent researcher and a well-known clinical researcher in cancer prevention who will train numerous minorities in research and increase the participation of minorities in biomedical research as investigators and patients.”

Abstract #1083 Marital status and adherence to scheduled free breast cancer screening among uninsured inner city women. Poster Session: Monday, April 4, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

Abstract #5018 Adherence to free breast cancer screening among uninsured black and Hispanic women. Poster Session: Wednesday, April 6, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

Abstract #1882 Short- and long-term risk of adenoma recurrence with cigarette smoking: An analysis of the Polyp Prevention Trial and Continued Follow-Up Study. Poster Session: Monday, April 4, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Monica Logan

Monica N. Logan, M.S.
Meharry Medical College, Nashville, TN
“After earning my Ph.D., I intend to pursue postdoctoral training in academia or government in a laboratory that focuses on either breast or prostate cancer disparities in African-Americans. After my postdoctoral training, I plan to continue my research career in academia where I can discover new therapeutic targets for cancer that will reduce morbidity and mortality of this disease.”

Abstract #2734 Genome-wide analysis of direct Nkx3.1 target genes. Poster Session: Monday, April 4, 2011, 1:00 p.m. - 5:00 p.m., Orange County Convention Center, Room W311 E-F

 

Awardees M-Z

Back to top